Rock Springs Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001595725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2024 · 109 positions · Total reported value $3.73B · Top-10 concentration 33.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 39.8% · 9 new · 28 cut · 8 exited

Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, Rock Springs Capital Management LP disclosed 109 equity positions with a combined reported value of $3.73B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 33.1% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were BPMC ($237.00M), IMCR ($153.91M), EVH ($130.75M). By sector, the heaviest allocations are Health Care 73.2%, Consumer Discretionary 5.0%. Versus the prior quarter, allocation shifted toward Health Care (+5.1pp), Consumer Staples (+0.6pp) and away from Other (-6.4pp).

Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 80% of names.

The largest new positions opened in Q1 2024 were SGRY ($29.38M), VKTX ($21.40M), NVO ($18.94M).

Of the 8 positions fully exited versus the prior quarter, the largest were KRTX ($163.01M), MRTX ($49.10M), IMGN ($22.52M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • SGRY SURGERY PARTNERS INC · $29.38M
  • VKTX VIKING THERAPEUTICS INC · $21.40M
  • NVO NOVO-NORDISK A S · $18.94M
  • PHVS PHARVARIS N V · $17.40M
  • VERA VERA THERAPEUTICS INC · $14.71M
  • CRNX CRINETICS PHARMACEUTICALS IN · $13.55M
  • CRL CHARLES RIV LABS INTL INC · $13.14M
  • DYN DYNE THERAPEUTICS INC · $12.83M

Fully Exited (vs previous quarter)

  • KRTX KARUNA THERAPEUTICS INC · prev qtr: $163.01M
  • MRTX MIRATI THERAPEUTICS INC · prev qtr: $49.10M
  • IMGN IMMUNOGEN INC · prev qtr: $22.52M
  • AMGN AMGEN INC · prev qtr: $21.46M
  • ICVX ICOSAVAX INC · prev qtr: $13.69M
  • INBX INHIBRX BIOSCIENCES INC · prev qtr: $11.45M
  • RLAY RELAY THERAPEUTICS INC · prev qtr: $7.42M

Insider Transactions (Form 4)

Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 104 US equity positions with a combined value of $2.05B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-78511 (status: Approved), registered 2013-09-27
  • Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 104 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 44.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 10.1%
  • Average position size: $19.70M

Sector Tilt

  • Health Care 96.8%
  • Industrials 1.1%
  • Consumer Discretionary 1.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 16 new, 35 added, 31 reduced, 12 exited
  • 22 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 73.2%
Technology 1.1%
Materials 0.1%
Other 18.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.50M $237.00M 6.36%
6.36%
Reduce
2 2.37M $153.91M 4.13%
4.13%
Reduce
3 3.99M $130.75M 3.51%
3.51%
Add
4 298.50K $119.13M 3.20%
3.20%
Hold
5 230.00K $113.78M 3.05%
3.05%
Hold
6 505.00K $112.71M 3.02%
3.02%
Reduce
7 179.25K $96.78M 2.60%
2.60%
Hold
8 1.18M $93.28M 2.50%
2.50%
Add
9 229.25K $90.26M 2.42%
2.42%
Hold
10 1.23M $84.41M 2.27%
2.27%
Hold
11 1.77M $82.87M 2.22%
2.22%
Add
12 596.75K $82.77M 2.22%
2.22%
Hold
13 103.25K $80.32M 2.16%
2.16%
Add
14 662.50K $76.76M 2.06%
2.06%
Hold
15 285.93K $76.36M 2.05%
2.05%
Add
16 1.06M $73.19M 1.96%
1.96%
Add
17 220.00K $72.14M 1.94%
1.94%
Hold
18 1.52M $65.99M 1.77%
1.77%
Hold
19 647.30K $61.86M 1.66%
1.66%
Hold
20 1.52M $61.19M 1.64%
1.64%
Hold
21 1.37M $57.59M 1.55%
1.55%
Add
22 2.37M $56.59M 1.52%
1.52%
Add
23 320.00K $54.85M 1.47%
1.47%
Reduce
24 137.25K $54.31M 1.46%
1.46%
Hold
25 1.26M $54.05M 1.45%
1.45%
Hold
26 8.84M $53.89M 1.45%
1.45%
Add
27 1.15M $51.63M 1.39%
1.39%
Add
28 1.76M $51.59M 1.39%
1.39%
Reduce
29 147.41K $51.11M 1.37%
1.37%
Reduce
30 1.86M $46.64M 1.25%
1.25%
Hold
31 392.25K $45.50M 1.22%
1.22%
Add
32 135.00K $43.96M 1.18%
1.18%
Add
33 290.00K $43.84M 1.18%
1.18%
Hold
34 327.60K $42.41M 1.14%
1.14%
Hold
35 694.75K $41.88M 1.12%
1.12%
Add
36 1.68M $39.41M 1.06%
1.06%
Hold
37 1.15M $37.16M 1.00%
1.00%
Add
38 3.54M $37.10M 1.00%
1.00%
Add
39 1.30M $32.84M 0.88%
0.88%
Add
40 2.11M $31.38M 0.84%
0.84%
Add
41 1.06M $30.84M 0.83%
0.83%
Hold
42 923.68K $29.77M 0.80%
0.80%
Add
43 4.78M $29.49M 0.79%
0.79%
Add
44 985.00K $29.38M 0.79%
0.79%
New
45 2.08M $28.31M 0.76%
0.76%
Add
46 3.68M $28.20M 0.76%
0.76%
Hold
47 130.50K $28.03M 0.75%
0.75%
Add
48 499.49K $28.02M 0.75%
0.75%
Add
49 8.14M $26.87M 0.72%
0.72%
Add
50 547.95K $23.16M 0.62%
0.62%
Reduce

FAQ

What did Rock Springs Capital Management LP buy in 2024-Q1?

In its 2024-Q1 13F filing, Rock Springs Capital Management LP reported 109 equity positions worth $3.73B in aggregate; its largest disclosed positions were BPMC ($237.00M), IMCR ($153.91M), EVH ($130.75M).

How large is Rock Springs Capital Management LP's portfolio?

Rock Springs Capital Management LP reported $3.73B of long equity holdings across 109 positions as of 2024-Q1. Top-10 holdings account for 33.1% of reported value.

What is Rock Springs Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rock-springs-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →